Zobrazeno 1 - 1
of 1
pro vyhledávání: '"L G Kapanadze"'
Publikováno v:
Kardiologiia. 61(7)
Aim Optimal combination therapy for chronic heart failure (CHF) currently implies the mandatory use of at least four classes of drugs: renin-angiotensin-aldosterone (RAAS) system inhibitors or angiotensin receptor blocker neprilysin inhibitors (ARNI)